UNSPSC 51182302: Human growth hormone or somatotropin or somatropin

This classification denotes a pituitary agent with the molecular formula C990H1528N262O300S7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NQX9KB6PCL, more generally known as somatropin. European Medicines Agency schedules somatropin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10584MIG. The term SOMATROPIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 1, no. 4, 1987, list 27.

SOMATROPIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: NONE.

UNSPSC 51182302 Human growth hormone or somatotropin or somatropin is a Commodity code covering pharmaceutical preparations of human growth hormone used in state and local healthcare, clinic, and institutional settings. State and local governments procure this product primarily through health departments, state Medicaid agencies, correctional health services, and public hospital systems to support treatment of growth disorders, endocrine deficiencies, and related clinical indications in eligible patient populations. The product itself is a prescription pharmaceutical requiring physician oversight and typically sourced through established pharmaceutical supply chains and specialty distributors.

The source provided contains no recent state and local contract opportunities tagged under this code. Without posted solicitations, RFPs, RFQs, or IFBs identifying specific issuing bodies, response dates, or geographic activity, no representative opportunities or market concentration can be characterized at this time.